BIOFLOR

This brand name is authorized in Cyprus, Hong Kong, Malta, Singapore

Active ingredients

The drug BIOFLOR contains one active pharmaceutical ingredient (API):

1 Saccharomyces boulardii CNCM I-745 UNII 978D8U419H - SACCHAROMYCES CEREVISIAE

Saccharomyces boulardii is an intestinal flora replacement which acts as antidiarrheal microorganisms in the digestive tract. During transit under its viable form in the digestive tract, saccharomyces boulardii exerts biological actions which are similar to the protective properties of the normal intestinal flora. Read about Saccharomyces boulardii

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BIOFLOR Capsule, hard	Υπουργείο Υγείας (CY)	MPI, EU: SmPC
BIOFLOR Powder for oral suspension	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07FA02	Saccharomyces boulardii	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms
Discover more medicines within A07FA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 30568, 41663
Country: MT	Medicines Authority	Identifier(s): MA239/00101, MA239/00102, MA239/00103
Country: SG	Health Sciences Authority	Identifier(s): 14722P, 14986P